Select Medical Holdings Corporation maintained earnings guidance for the year ending December 31, 2023. For the year, the company expected revenue to be in the range of $6.55 billion to $6.7 billion and fully diluted earnings per share to be in the range of $1.77 to $1.94.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
34.01 USD | -0.67% | -2.61% | +44.72% |
May. 06 | UBS Adjusts Select Medical Price Target to $34 From $31, Maintains Neutral Rating | MT |
May. 06 | Benchmark Adjusts Price Target on Select Medical Holdings to $42 From $39, Maintains Buy Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+44.72% | 4.42B | |
+17.63% | 83.4B | |
+2.04% | 27.04B | |
-11.48% | 16.96B | |
-1.57% | 16.86B | |
+2.89% | 15.76B | |
+1.25% | 12.76B | |
+73.23% | 13.33B | |
+72.58% | 12.74B | |
+2.08% | 12.32B |
- Stock Market
- Equities
- SEM Stock
- News Select Medical Holdings Corporation
- Select Medical Holdings Corporation Maintains Earnings Guidance for the Year Ending December 31, 2023